Abstract 3528: Quantitation of ATM function in primary CLL cells.

Yingjun Jiang; Xiaojun Liu; Sijin Wen; Kim-Anh Do; Xiaoping Su; Michael J. Keating; William Wierda; William Plunkett

doi:10.1158/1538-7445.AM2013-3528

Clinical Research

Abstract 3528: Quantitation of ATM function in primary CLL cells.

Yingjun Jiang, Xiaojun Liu, Sijin Wen, Kim-Anh Do, Xiaoping Su, Michael J. Keating, William Wierda and William Plunkett

Yingjun Jiang

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiaojun Liu

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sijin Wen

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kim-Anh Do

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiaoping Su

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Keating

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William Wierda

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William Plunkett

UT M.D. Anderson Cancer Center, Houston, TX.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1538-7445.AM2013-3528 Published April 2013

Article
Info & Metrics

Article Information

Volume 73, Issue 8 Supplement, pp. 3528

DOI

https://doi.org/10.1158/1538-7445.AM2013-3528

Published By

American Association for Cancer Research

Print ISSN

0008-5472

Online ISSN

1538-7445

Author Information

Yingjun Jiang,
Xiaojun Liu,
Sijin Wen,
Kim-Anh Do,
Xiaoping Su,
Michael J. Keating,
William Wierda, and
William Plunkett

UT M.D. Anderson Cancer Center, Houston, TX.

April 2013
Volume 73, Issue 8 Supplement

Table of Contents
Index by Author

Search for this keyword

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Abstract 3528: Quantitation of ATM function in primary CLL cells.

Message Subject (Your Name) has forwarded a page to you from Cancer Research

Message Body (Your Name) thought you would be interested in this article in Cancer Research.

Your Personal Message

Citation Tools

Abstract 3528: Quantitation of ATM function in primary CLL cells.

Yingjun Jiang, Xiaojun Liu, Sijin Wen, Kim-Anh Do, Xiaoping Su, Michael J. Keating, William Wierda and William Plunkett

Cancer Res April 15 2013 (73) (8 Supplement) 3528; DOI: 10.1158/1538-7445.AM2013-3528

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Abstract 3528: Quantitation of ATM function in primary CLL cells.

Yingjun Jiang, Xiaojun Liu, Sijin Wen, Kim-Anh Do, Xiaoping Su, Michael J. Keating, William Wierda and William Plunkett

Cancer Res April 15 2013 (73) (8 Supplement) 3528; DOI: 10.1158/1538-7445.AM2013-3528

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics

Cited By...

Clinical Research

Abstract LB-139: Efficacy, safety, and changes in blood markers following sunitinib monotherapy in patients with advanced hepatocellular carcinoma: Experience from a multidisciplinary Phase II study
Abstract LB-141: The Adenoma Prevention with Celecoxib (APC) trial: Five-year efficacy and safety results
Abstract LB-306: A Phase II study of the efficacy and tolerability of Lapatinib in patients with advanced hepatocellular carcinomas.

Show more 3

Poster Presentations - Proffered Abstracts

Abstract A47: Inhibition of histone methyltransferase with novel epipolythiodioxopiperazines (ETP) alkaloids in pediatric high-grade glioma
Abstract A16: The in vitro and in vivo activity of the pyrrolomycin marinopyrrole RL71 alone and combined with temsirolimus (TEM) in MYCN-amplified neuroblastoma (NB)
Abstract B09: IL6 and CXCL8 mediate redundant tumor-host signaling pathways that facilitate osteosarcoma lung metastasis

Show more 3

Poster Presentations - New Agents Targeting Signaling Pathways 2: Clinical Trials and Other Patient-Based Studies

Abstract 3516: AZD1208 PIM kinase inhibitor - Preliminary evidence of target pathway inhibition in Phase I clinical trials of AML.
Abstract 3521: B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.
Abstract 3518: Frequent mutation and deletion of GATA4 in hepatocellular carcinoma represses proliferation terminating late-maturation genes CEBPD and HNF4A by reversible epigenetic mechanisms.

Show more 3

Main menu

User menu

Search

Abstract 3528: Quantitation of ATM function in primary CLL cells.

Article Information

Author Information

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Clinical Research

Poster Presentations - Proffered Abstracts

Poster Presentations - New Agents Targeting Signaling Pathways 2: Clinical Trials and Other Patient-Based Studies

Articles

Info for

About Cancer Research